0 228

Cited 10 times in

Effect of Deflazacort on bone mineral density in renal transplant recipients

Authors
 M.S. Kim  ;  Y.S. Kim  ;  S.K. Lim  ;  S.I. Kim  ;  J.I. Moon  ;  K. Park 
Citation
 TRANSPLANTATION PROCEEDINGS, Vol.30(7) : 3041-3042, 2002 
Journal Title
 TRANSPLANTATION PROCEEDINGS 
ISSN
 0041-1345 
Issue Date
2002
MeSH
Amino Acids/urine ; Biomarkers/blood ; Biomarkers/urine ; Bone Density/drug effects* ; Bone Density/physiology ; Graft Survival ; Humans ; Immunosuppressive Agents/therapeutic use* ; Kidney Transplantation/physiology* ; Osteocalcin/blood ; Osteocalcin/urine ; Osteoporosis/prevention & control ; Postoperative Complications/prevention & control ; Prednisone/therapeutic use* ; Pregnenediones/therapeutic use*
Abstract
Corticosteroids are mainly responsible for posttransplantation (Tx) osteoporosis.1 The clinical trial of deflazacort (DFZ) with a biologically equivalent dose of conventional steroid revealed a less detrimental effect on bone metabolism.2 We tried elective conversion from prednisone (PDS) to DFZ in recipients with stable graft function 1 year after post-Tx to confirm the bone-sparing effect of DFZ.
Full Text
http://www.sciencedirect.com/science/article/pii/S004113459800921X#
DOI
10.1016/S0041-1345(98)00921-X
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Myoung Soo(김명수) ORCID logo https://orcid.org/0000-0002-8975-8381
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/144067
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links